By Finance Pulse in investment —

Surrozen Stock Upgraded After Promising Phase 1b Results

Surrozen's stock receives a 'Buy' upgrade due to positive results from Phase 1b trials, boosting investor confidence in the biotech company's future prospects.

A visually appealing image showing a rising stock graph over a blurred scientific lab background, sy
Surrozen Stock Upgraded After Promising Phase 1b Results

Surrozen upgraded to Buy following positive Phase 1b data.

Source